Webinar | December 20, 2022

Maintaining Data Integrity And Compliance Of Your Osmometer

Data integrity issues are a leading issue cited in FDA warning letters, mainly due to incomplete data. In the pharma and biotech industries, this can be prevented by ensuring the trustworthiness and reliability of electronic records, a process that is also known as compliance with data integrity. The highest risks, when not working in a compliant manner, lie in import bans, product recalls, or even the closing of production plants.

Learn about what data integrity is for the pharma and biotech industries, how your analytical instruments can be 21 CFR part 11 and EU Annex 11 compliant for data integrity and electronic record management, and the value of osmolality testing as a key process parameter in the pharma and biotech industries.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene